TriSalus Life Sciences, Inc. (TLSI)
NASDAQ: TLSI · Real-Time Price · USD
4.650
+0.185 (4.14%)
At close: Mar 9, 2026, 4:00 PM EDT
4.615
-0.035 (-0.75%)
After-hours: Mar 9, 2026, 4:10 PM EDT
TriSalus Life Sciences Market Cap
TriSalus Life Sciences has a market cap or net worth of $285.07 million as of March 9, 2026. Its market cap has increased by 63.44% in one year.
Market Cap
285.07M
Enterprise Value
300.92M
1-Year Change
63.44%
Ranking
Category
Stock Price
$4.65
Market Cap Chart
Since February 8, 2021, TriSalus Life Sciences's market cap has decreased from $328.75M to $285.07M, a decrease of -13.29%. That is a compound annual growth rate of -2.77%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 6, 2026 | 273.73M | -21.51% |
| Dec 31, 2025 | 348.75M | 128.28% |
| Dec 31, 2024 | 152.77M | -31.30% |
| Dec 29, 2023 | 222.38M | -29.05% |
| Dec 30, 2022 | 313.44M | 1.52% |
| Dec 31, 2021 | 308.75M | -6.08% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Standard BioTools | 384.57M |
| Cerus | 373.77M |
| Viemed Healthcare | 358.04M |
| ClearPoint Neuro | 343.89M |
| Delcath Systems | 317.58M |
| RxSight | 310.32M |
| Senseonics Holdings | 265.03M |
| Quanterix | 240.33M |